These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22025384)
1. Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness. Terada N; Shiraishi T; Zeng Y; Mooney SM; Yeater DB; Mangold LA; Partin AW; Kulkarni P; Getzenberg RH Prostate; 2012 Jun; 72(9):966-76. PubMed ID: 22025384 [TBL] [Abstract][Full Text] [Related]
2. Cyr61 is a potential prognostic marker for prostate cancer. Terada N; Kulkarni P; Getzenberg RH Asian J Androl; 2012 May; 14(3):405-8. PubMed ID: 22343491 [TBL] [Abstract][Full Text] [Related]
3. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer. Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169 [TBL] [Abstract][Full Text] [Related]
4. Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells. Marra M; Santini D; Meo G; Vincenzi B; Zappavigna S; Baldi A; Rosolowski M; Tonini G; Loeffler M; Lupu R; Addeo SR; Abbruzzese A; Budillon A; Caraglia M Int J Cancer; 2009 Nov; 125(9):2004-13. PubMed ID: 19530242 [TBL] [Abstract][Full Text] [Related]
5. Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor. Chu LY; Zhou JY; Zhao YX; Ou YT; Yang T; Peng YH; Fang WK; Xu YW; Xie JJ Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085702 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment. D'Antonio KB; Schultz L; Albadine R; Mondul AM; Platz EA; Netto GJ; Getzenberg RH Clin Cancer Res; 2010 Dec; 16(23):5908-13. PubMed ID: 21138874 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Sun ZJ; Wang Y; Cai Z; Chen PP; Tong XJ; Xie D Br J Cancer; 2008 Nov; 99(10):1656-67. PubMed ID: 18941464 [TBL] [Abstract][Full Text] [Related]
8. Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells. Lee YJ; Lee DM; Lee SH Food Chem Toxicol; 2013 Aug; 58():169-76. PubMed ID: 23623839 [TBL] [Abstract][Full Text] [Related]
9. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Singh S; Singh R; Sharma PK; Singh UP; Rai SN; Chung LW; Cooper CR; Novakovic KR; Grizzle WE; Lillard JW Cancer Lett; 2009 Sep; 283(1):29-35. PubMed ID: 19375853 [TBL] [Abstract][Full Text] [Related]
10. A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk. Tao L; Chen J; Zhou H; Qin C; Li P; Cao Q; Li J; Ju X; Zhu C; Wang M; Zhang Z; Shao P; Yin C Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):95-100. PubMed ID: 23045290 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer. Sarwar M; Sandberg S; Abrahamsson PA; Persson JL Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid. Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385 [TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix associated protein CYR61 is linked to prostate cancer development. D'Antonio KB; Toubaji A; Albadine R; Mondul AM; Platz EA; Netto GJ; Getzenberg RH J Urol; 2010 Apr; 183(4):1604-10. PubMed ID: 20172544 [TBL] [Abstract][Full Text] [Related]
14. Cyr61 is up-regulated in prostate cancer and associated with the p53 gene status. Lv H; Fan E; Sun S; Ma X; Zhang X; Han DM; Cong YS J Cell Biochem; 2009 Mar; 106(4):738-44. PubMed ID: 19180570 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum cysteine-rich protein 61 levels in patients with coronary artery disease. Deng J; Qian X; Li J; Li Y; Li Y; Luo Y Biomark Med; 2018 Apr; 12(4):329-339. PubMed ID: 29345157 [TBL] [Abstract][Full Text] [Related]
16. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells. Chin LH; Hsu SP; Zhong WB; Liang YC Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758 [TBL] [Abstract][Full Text] [Related]
17. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress. Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991 [TBL] [Abstract][Full Text] [Related]
18. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway. Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920 [TBL] [Abstract][Full Text] [Related]